Your browser doesn't support javascript.
loading
Remdesivir Resistance in Transplant Recipients With Persistent Coronavirus Disease 2019.
Hogan, John I; Duerr, Ralf; Dimartino, Dacia; Marier, Christian; Hochman, Sarah E; Mehta, Sapna; Wang, Guiqing; Heguy, Adriana.
Afiliação
  • Hogan JI; Department of Medicine, NYU Long Island School of Medicine, Mineola, New York, USA.
  • Duerr R; Department of Microbiology, NYU Grossman School of Medicine, New York, New York, USA.
  • Dimartino D; Genome Technology Center, NYU Langone Health, New York, New York, USA.
  • Marier C; Genome Technology Center, NYU Langone Health, New York, New York, USA.
  • Hochman SE; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
  • Mehta S; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
  • Wang G; Department of Medicine, NYU Grossman School of Medicine, New York, New York, USA.
  • Heguy A; Genome Technology Center, NYU Langone Health, New York, New York, USA.
Clin Infect Dis ; 76(2): 342-345, 2023 01 13.
Article em En | MEDLINE | ID: mdl-36156117
ABSTRACT
New mutations conferring resistance to SARS-CoV-2 therapeutics have important clinical implications. We describe the first cases of an independently acquired V792I RNA-dependent RNA polymerase mutation developing in renal transplant recipients after remdesivir exposure. Our work underscores the need for augmented efforts to identify concerning mutations and address their clinical implications.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article